Skip to main content
Article
Significant differences in outcome between Immunoscore categories in stage I colon cancer patients.
Annals of Oncology (2019)
  • J Galon, French Institute of Health and Medical Research
  • F Hermitte, HalioDx, Marseille, France
  • B Mlecnik, French Institute of Health and Medical Research
  • F Marliot, AP-HP, Paris, France
  • Carlo Bifulco, Providence Portland Medical Center
  • A Lugli, University of Bern
  • I Nagtegaal, Radboud University Nijmegen
  • A Hartmann, Erlangen-Nürnberg University, Erlangen, Germany
  • M Van den Eynde, Clin. Univ. St-Luc Bruxelles, Brussels, Belgium
  • M Roehrl, Memorial Sloan Kettering Cancer Center
  • P Ohashi, Princess Margaret Cancer Centre
  • E Zavadova, Charles University in Prague
  • T Torigoe, Sapporo Medical University
  • P Patel, The Gujarat Cancer & Research Institute, Ahmedabad, India
  • Y Wang, Xi'an Jiaotong University
  • Y Kawakami, Keio University
  • F Marincola, AbbVie
  • P Ascierto, Instituo Nazionale Tumori IRCCS, Naples, Italy
  • Bernard A Fox, Robert W. Franz Cancer Center, Portland, Oregon, USA
  • F Pagès, AP-HP, Paris, France
Publication Date
July 1, 2019
DOI
10.1093/ANNONC/MDZ154.022
Citation Information
J Galon, F Hermitte, B Mlecnik, F Marliot, et al.. "Significant differences in outcome between Immunoscore categories in stage I colon cancer patients." Annals of Oncology Vol. 30 (2019) p. 134
Available at: http://works.bepress.com/carlo-bifulco/59/